Global Enteral Feeding Formulas Market Report, 2019: Analysis & Forecast, 2017 to 2026 – ResearchAndMarkets.com
According to this research, the Global Enteral Feeding Formulas market accounted for
Some of the key factors influencing the market growth include rising prevalence of chronic diseases and disorders, growing geriatric population, growing number of preterm births and rising demand for homecare. However, complications associated with enteral feeding are hindering the market growth.
Amongst Product, the standard formulas segment has considerable growth during the forecast period. The growth of this segment can be attributed to their extensive use in a majority of enterally fed patients, especially chronically tube-fed patients.
By Geography,
Some of the key players in global enteral feeding formulas market are Abbott Laboratories, Novartis AG,
What the report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Enteral Feeding Formulas Market, By Product
5.1 Introduction
5.2 Disease-Specific Formulas
5.2.1 Hepatic Formulas
5.2.2 Renal Formulas
5.2.3 Pulmonary Formulas
5.2.4 Liver Formulas
5.2.5 Immuno Modulatory Formulas
5.2.6 Gastrointestinal Dysfunction Formulas
5.2.7 Diabetic Formulas
5.2.8 Other Formulas
5.3 Standard Formulas
5.3.1 Monomeric Formulas
5.3.2 Polymeric Formulas
5.3.3 Calorie Dense Products
5.3.3.1 1.0 Calorie/ML
5.3.3.2 1.2 Calorie/ML
5.3.3.3 1.5 Calorie/ML
5.3.3.4 2.0 Calorie/ML
5.4 Blenderized Formula
5.4.1 Vegetables
5.4.2 Rice
5.4.3 Fruits
5.4.3.1 Avocado
5.4.3.2 Bananas
5.4.3.3 Raspberries
5.4.3.4 Sweet Potatoes
5.4.3.5 Strawberries
5.4.3.6 Quinoa
5.4.3.7 Blueberries
5.4.3.8 Other Fruits
5.4.4 Flax seed
5.4.5 Meat
5.4.6 Other Blenderized Formulas
5.5 Fiber Supplemented Formula
5.6 Semi-Elemental Formula
5.7 Polymeric Formula
5.8 Elemental Formula
5.9 Hydrolyzed Formula
5.10 Other Products
6 Global Enteral Feeding Formulas Market, By Stage
6.1 Introduction
6.2 Pediatrics
6.2.1 Oral Supplements
6.2.2 Tube Feeding Formulas
6.2.3 Infant Formulas
6.3 Adults
6.3.1 Modulars
6.3.2 Oral Supplements
6.3.3 Tube Feeding Formulas
7 Global Enteral Feeding Formulas Market, By Form
7.1 Introduction
7.2 Liquid
7.3 Powder
7.4 Other Forms
8 Global Enteral Feeding Formulas Market, By Mode of Delivery
8.1 Introduction
8.2 Oral
8.3 Trans-pyloric
8.3.1 Gastro-Jejunostomy
8.3.2 Naso-Jejunal
8.3.3 Jejunostomy
8.4 Gastric
8.4.1 Gastrostomy
8.4.2 Nasogastric
9 Global Enteral Feeding Formulas Market, By Flavor Type
9.1 Introduction
9.2 Flavored
9.2.1 Vanilla
9.2.2 Butter Pecan
9.2.3 Strawberry
9.2.4 Other Flavors
9.3 Unflavored
10 Global Enteral Feeding Formulas Market, By Therapeutic Area
10.1 Introduction
10.2 Malabsorption
10.3 Crohn's disease
10.4 Cystic Fibrosis
10.5 Congenital Heart Disease
10.6 Kidney Failure
10.7 Choanal atresia
10.8 Inflammatory bowel disease
10.9 Short Bowel Syndrome
10.10 Other Therapeutic Areas
11 Global Enteral Feeding Formulas Market, By Application
11.1 Introduction
11.2 Gastroenterology
11.3 Diabetes
11.4 Neurology
11.5 Oncology
11.6 Critical Care
11.7 Other Applications
12 Global Enteral Feeding Formulas Market, By End User
12.1 Introduction
12.2 Long-Term Care Facilities
12.2.1 Assisted Living Facilities
12.2.2
12.2.3 Home Care Agencies and Hospices
12.3 Hospitals
13 Global Enteral Feeding Formulas Market, By Geography
13.1 Introduction
13.2
13.2.1 US
13.2.2
13.2.3
13.3
13.3.1
13.3.2
13.3.3
13.3.4
13.3.5
13.3.6 Rest of
13.4
13.4.1
13.4.2
13.4.3
13.4.4
13.4.5
13.4.6
13.4.7 Rest of
13.5
13.5.1
13.5.2
13.5.3
13.5.4 Rest of
13.6
13.6.1
13.6.2
13.6.3
13.6.4
13.6.5 Rest of
14 Key Developments
14.1 Agreements, Partnerships,
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.4 Expansions
14.5 Other Key Strategies
15 Company Profiling
15.1 Abbott Laboratories
15.2 Novartis AG
15.3
15.4 Nestle S.A.
15.5 Trovita Health Science
15.6 Danone Nutricia
15.7 Fresenius Kabi
15.8 Hormel Foods Corporation
15.9 Meiji Holdings Co. Ltd.
15.10
15.11
15.12
15.13 Merck & Co. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ije76y
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005708/en/
ResearchAndMarkets.com
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices
Source:
Drug cost bill advances but GOP resistance spells trouble
Booker takes on Biden in bid to break through crowded field
Advisor News
- CFP Board reports record growth in professionals and exam candidates
- GRASSLEY: WORKING FAMILIES TAX CUTS LAW SUPPORTS IOWA'S FAMILIES, FARMERS AND MORE
- Retirement Reimagined: This generation says it’s no time to slow down
- The Conversation Gap: Clients tuning out on advisor health care discussions
- Wall Street executives warn Trump: Stop attacking the Fed and credit card industry
More Advisor NewsAnnuity News
- Retirees drive demand for pension-like income amid $4T savings gap
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
More Annuity NewsHealth/Employee Benefits News
- Kaiser affiliates will pay $556M to settle a lawsuit alleging Medicare fraud
- Final day to select ACA health plans arrives in most states, with no subsidy deal yet
- More Texans have signed up for ACA health coverage despite expiring subsidies, falling national enrollment
- There’s Still Time: Massachusetts Health Connector Open Enrollment Continues Through January 23
- Iowa House Democrats roll out affordability plan, take aim at Reynolds’ priorities
More Health/Employee Benefits NewsLife Insurance News